Easywell Biomedicals, Inc.

Easywell Biomedicals, Inc.verified

1799.TWO

Price:

$32.75

Market Cap:

$4.08B

Easywell Biomedicals, Inc. develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in the United States and Asia. It develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; and TLX-011 for treatment of inflammatory lesions of rosacea. The company also develops TWB-201 for Parkinson patch; TLX-501, an urinary medicine; and TLX-502, a pneumonia medicine, as well as provides medical devices. It has ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-12-31

Stock Exchange

TWO

Ticker

1799.TWO

The PE Ratio as of December 2025 (TTM) for Easywell Biomedicals, Inc. (1799.TWO) is -62.98

According to Easywell Biomedicals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -62.98. This represents a change of -93.64% compared to the average of -991.00 of the last 4 quarters.

Easywell Biomedicals, Inc. (1799.TWO) Historical PE Ratio (quarterly & annually)

How has 1799.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Easywell Biomedicals, Inc. over the last ten years is -25.98. The current -62.98 PE Ratio has changed 24.14% with respect to the historical average. Over the past ten years (40 quarters), 1799.TWO's PE Ratio was at its highest in in the December 2022 quarter at -9.93. The PE Ratio was at its lowest in in the March 2025 quarter at -3298.29.

Quarterly (TTM)
Annual

Average

-25.98

Median

-14.44

Minimum

-79.28

Maximum

-4.42

Easywell Biomedicals, Inc. (1799.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Easywell Biomedicals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 201.41%

Maximum Annual PE Ratio = -4.42

Minimum Annual Increase = -26.69%

Minimum Annual PE Ratio = -79.28

Quarterly (TTM)
Annual
YearPE RatioChange
2024-79.28148.62%
2023-31.89179.62%
2022-11.40-26.69%
2021-15.5616.68%
2020-13.33201.41%

Easywell Biomedicals, Inc. (1799.TWO) Average PE Ratio

How has 1799.TWO PE Ratio performed in the past?

The current PE Ratio of Easywell Biomedicals, Inc. (1799.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-40.86

5-year avg

-30.29

10-year avg

-25.98

Easywell Biomedicals, Inc. (1799.TWO) PE Ratio vs. Peers

How is 1799.TWO’s PE Ratio compared to its peers?

Easywell Biomedicals, Inc.’s PE Ratio is less than Orient EuroPharma Co., Ltd. (-11.97), less than Orient Pharma Co., Ltd. (71.25), less than BioGend Therapeutics Co., Ltd. (-36.69), less than Onyx Healthcare Inc. (35.74), less than Bionime Corporation (-34.88), less than AnnJi (-13.61), greater than Medigen Biotechnology Corp. (-68.22), less than UnicoCell Biomed Co., Ltd. (-54.07), greater than Formosa Pharmaceuticals, Inc. (-69.19), greater than Mercury Biopharmaceutical Corporation (-63.71),

Build a custom stock screener for Easywell Biomedicals, Inc. (1799.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Easywell Biomedicals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Easywell Biomedicals, Inc. (1799.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Easywell Biomedicals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Easywell Biomedicals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Easywell Biomedicals, Inc. (1799.TWO)?

What is the highest PE Ratio for Easywell Biomedicals, Inc. (1799.TWO)?

What is the 3-year average PE Ratio for Easywell Biomedicals, Inc. (1799.TWO)?

What is the 5-year average PE Ratio for Easywell Biomedicals, Inc. (1799.TWO)?

How does the current PE Ratio for Easywell Biomedicals, Inc. (1799.TWO) compare to its historical average?